156 related articles for article (PubMed ID: 35945708)
1. Immunotherapy as a treatment modality for mucosal melanoma of the head and neck: A systematic review.
Wehbe J; Jaikaransingh D; Walker A
Medicine (Baltimore); 2022 Aug; 101(31):e29979. PubMed ID: 35945708
[TBL] [Abstract][Full Text] [Related]
2. Definitive treatment for head and neck mucosal melanoma.
Nomura M
Jpn J Clin Oncol; 2023 Dec; 53(12):1112-1118. PubMed ID: 37609679
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
4. Importance of Margins, Radiotherapy, and Systemic Therapy in Mucosal Melanoma of the Head and Neck.
Sahovaler A; Ziai H; Cardemil F; Huang SH; Su J; Goldstein DP; Gilbert R; Hosni A; Hope A; Waldron J; Spreafico A; Monteiro E; Witterick I; Irish J; Gullane P; Xu W; O'Sullivan B; de Almeida JR
Laryngoscope; 2021 Oct; 131(10):2269-2276. PubMed ID: 33856051
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of postoperative adjuvant therapy for head and neck mucosal melanoma in China.
Yin G; Guo W; Huang Z; Chen X
Acta Otolaryngol; 2021 Nov; 141(11):1014-1021. PubMed ID: 34766867
[TBL] [Abstract][Full Text] [Related]
6. Primary malignant mucosal melanoma of the head and neck region: pooled analysis of 60 published cases from India and review of literature.
Pandey M; Mathew A; Iype EM; Sebastian P; Abraham EK; Nair KM
Eur J Cancer Prev; 2002 Feb; 11(1):3-10. PubMed ID: 11917203
[TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
[TBL] [Abstract][Full Text] [Related]
8. Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.
Falcone R; Verkhovskaia S; Di Pietro FR; Poti G; Samela T; Carbone ML; Morelli MF; Zappalà AR; di Rocco ZC; Morese R; Piesco G; Marchetti P; Failla CM; De Galitiis F
Curr Oncol; 2024 Jan; 31(1):588-597. PubMed ID: 38275835
[TBL] [Abstract][Full Text] [Related]
9. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
Schaefer T; Satzger I; Gutzmer R
Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
[TBL] [Abstract][Full Text] [Related]
10. An update on the current management of head and neck mucosal melanoma.
Green B; Elhamshary A; Gomez R; Rahimi S; Brennan PA
J Oral Pathol Med; 2017 Aug; 46(7):475-479. PubMed ID: 27864904
[TBL] [Abstract][Full Text] [Related]
11. Review: mucosal melanoma of the head and neck.
Gavriel H; McArthur G; Sizeland A; Henderson M
Melanoma Res; 2011 Aug; 21(4):257-66. PubMed ID: 21540752
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival in head and neck mucosal melanoma.
Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074
[TBL] [Abstract][Full Text] [Related]
13. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F
Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303
[TBL] [Abstract][Full Text] [Related]
14. Clinical patterns and management of primary mucosal melanoma: a single centre experience.
Ng YYR; Tan GHC; Quek RHH; Farid MBHR; Soo KC; Teo MCC
ANZ J Surg; 2018 Nov; 88(11):1145-1150. PubMed ID: 29388353
[TBL] [Abstract][Full Text] [Related]
15. What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?
Edmond M; Nenclares P; Harrington K; Ap Dafydd D; Bagwan I; Begg D; Lingley K; Patterson G; Payne M; Steven N; Turnbull N; Yip K; Silva P; Kerawala C; Paleri V; King E
Head Neck; 2021 Nov; 43(11):3498-3503. PubMed ID: 34453460
[TBL] [Abstract][Full Text] [Related]
16. Mucosal Melanoma: a Literature Review.
Yde SS; Sjoegren P; Heje M; Stolle LB
Curr Oncol Rep; 2018 Mar; 20(3):28. PubMed ID: 29569184
[TBL] [Abstract][Full Text] [Related]
17. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective.
Al-Qurayshi Z; Hassan M; Srivastav S; Sperry S; Pagedar N; Hamner J; Kandil E
Oncology; 2017; 93(1):18-28. PubMed ID: 28423377
[TBL] [Abstract][Full Text] [Related]
18. Primary malignant mucosal melanoma of the head and neck.
Bradley PJ
Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):100-4. PubMed ID: 16552267
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
Andtbacka RH; Agarwala SS; Ollila DW; Hallmeyer S; Milhem M; Amatruda T; Nemunaitis JJ; Harrington KJ; Chen L; Shilkrut M; Ross M; Kaufman HL
Head Neck; 2016 Dec; 38(12):1752-1758. PubMed ID: 27407058
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of mucosal melanoma of the head and neck.
Frakes JM; Strom TJ; Naghavi AO; Trotti A; Rao NG; McCaffrey JC; Otto KJ; Padhya T; Caudell JJ
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):268-73. PubMed ID: 26597431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
